3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Ovarian Neoplasms
8
Breast Neoplasms
8
Carcinoma, Ovarian Epithelial
4
Carcinoma, Non-Small-Cell Lung
4
Fallopian Tube Neoplasms
3
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma
2
Uterine Neoplasms
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Unresectable Stage III NSCLC
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thrombocytopenia
1
Primary Breast Cancer
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Pathologic Complete Response
1
Paranasal Sinus Neoplasms
1
Ovarian Diseases
1
Neutropenia
1
Neoplasms, Unknown Primary
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasms
1
Neoplasm Metastasis
1
Interventions
pembrolizumab
5
Paclitaxel
4
Ifosfamide
4
Cisplatin
4
Nivolumab
3
avelumab
2
aldesleukin
2
Radiotherapy
2
Magnetic Resonance Spectroscopy
2
Adoptive Transfer
2
vinflunine
1
toripalimab
1
rocakinogene sifuplasmid
1
niraparib
1
nimotuzumab
1
lenvatinib
1
enfortumab vedotin
1
durvalumab
1
dostarlimab
1
dacomitinib
1
cemiplimab
1
cabazitaxel
1
Vorinostat
1
VGX-3100
1
Ultrasonography
1
Surveys and Questionnaires
1
Sildenafil Citrate
1
Sentinel Lymph Node Biopsy
1
Psychiatric Rehabilitation
1
Psychiatric Nursing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Penile Neoplasms
×
CP protocol
×
Clear all
NCT06353906
2025-12-08
PRIAM
The Netherlands Cancer Institute
Phase 2
Recruiting
27 enrolled